Screener
Summit Therapeutics SMMT Free cash flow margin
Discontinued — last reported Q3 '22
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Summit Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Summit Therapeutics’s 10-Q, filed November 7, 2023. Open the filing →
- Filed
- Nov 7, 2023, 8:08 AM EST
- Fiscal quarter
- Q3 FY2023
- Calendar quarter
- Q3 2023
- Accession
- 0001599298-23-000098
FAQ
- What is Summit Therapeutics's free cash flow margin?
- Summit Therapeutics (SMMT) reported free cash flow margin of -5,931.6% in Q3 2022.
- How has Summit Therapeutics's free cash flow margin changed year-over-year?
- Summit Therapeutics's free cash flow margin decreased by 44.4% year-over-year, from -4,108.7% to -5,931.6%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Summit Therapeutics's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude